NR0B2 and neoplasm: If PKC-θ affects NK cell cytotoxicity through a dominant alternative pathway to SHP-1, then we would expect the observed phenotype of SHP-1 silenced/mutated NK cells (highly increased killing and arrest of tumor growth) to be abrogated, at least partially, upon PKC-θ silencing.